MDxHealth (MDXH) Raw Materials (2023 - 2025)

MDxHealth has reported Raw Materials for 3 years, with the latest figure at $6.9 million in Q4 2025.

• Quarterly Raw Materials rose 78.26% year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (up 78.26% YoY) and the FY2025 annual result came in at $6.9 million, up 78.26% from the prior year.
• Raw Materials improved to $6.9 million in Q4 2025 per MDXH's latest filing, from $3.9 million in the prior quarter.
• Over five years, Raw Materials peaked at $6.9 million in Q4 2025 and troughed at $2.8 million in Q4 2023.
• A 3-year average of $4.5 million and a median of $3.9 million in 2024 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2024 and 2025: Raw Materials jumped 39.22% in 2024, then surged 78.26% in 2025.
• Over 3 years, Raw Materials stood at $2.8 million in 2023, then surged by 39.22% to $3.9 million in 2024, then soared by 78.26% to $6.9 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $6.9 million, $3.9 million, and $2.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.